OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Merck & Co Inc/  US58933Y1055  /

IEX
12/8/2021  9:59:54 PM Chg. +0.93 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
73.22USD +1.29% 504,022
Turnover: 36.66 mill.		 -Bid Size: - -Ask Size: - 185.22 bill.USD 3.39% 26.24
GlobeNewswire 12/8 SOTIO Announces Clinical Collaboration with MSD to Evaluate IL-15 Superagonist, SOT101, in Combinati...
TeleTrader 12/3 Canada secures COVID oral antiviral treatment
TeleTrader 12/1 Belgium looking to buy 10,000 Merck COVID pills
TeleTrader 11/30 FDA panel backs Merck's at-home COVID pill
TeleTrader 11/26 Merck revises down its COVID-19 drug efficacy
TeleTrader 11/9 US to buy 1.4M courses of Merck's COVID-19 drug
TeleTrader 11/7 Merck's COVID drug to be rolled out this month in UK
TeleTrader 11/4 UK first in the world to approve Merck's virus drug
TeleTrader 10/28 Merck's Q3 revenue rises to $13.2B after 20% jump
TeleTrader 10/26 France orders 50,000 Merck COVID drug doses
TeleTrader 10/25 Merck, Xeris announce collaboration agreement
TeleTrader 10/25 EMA starts rolling review of Merck COVID drug
TeleTrader 10/20 UK secures Merck, Pfizer COVID drug supplies
GlobeNewswire 10/14 The Alliance for Advancing Health Online Invests $7M+ through the Vaccine Confidence Fund to Boost V...
TeleTrader 10/12 Everest Organics to make Merck COVID pill ingredient
TeleTrader 10/12 Merck wants to double supply of its COVID drug
TeleTrader 10/11 Merck, Ridgeback seek FDA approval for COVID pill
TeleTrader 10/6 Merck signs deal to deliver its COVID-19 drug to Singapore
TeleTrader 10/5 WHO: Merck's COVID drug is good news
TeleTrader 10/1 Merck-Ridgeback COVID drug cuts hospitalizations, deaths by 50%
TeleTrader 9/30 Merck hopes COVID drug approved before 2021 ends
TeleTrader 9/30 Merck acquires Acceleron in $11.5B deal
TeleTrader 9/28 Merck close to buying Acceleron for $11B - report
TeleTrader 9/1 Merck announces phase 3 study of its COVID-19 drug
GlobeNewswire 8/18 Telix and Merck to Commence Pan-Cancer Clinical Combination Studies